or ceftazidime, and the plates were incubated overnight at 37°C. Lactosefermenting colonies were identifi ed as E. coli by using standard biochemical methods, which included sulfi de indole motility, growth on triple sugar iron medium, oxidase activity testing, and the API20E system (bioMérieux, Durham, NC, USA) as needed.
Antimicrobial drug susceptibility was determined by using the disk diffusion method (AB Biodisk, Solna, Sweden) according to the manufacturer's instructions and interpreted according to the criteria of the Clinical and Laboratory Standards Institute (4). Isolates were screened for extended-spectrum β-lactamase (ESBL) production by using the double-disk diffusion method and for acquired ampC-type β-lactamase genes by using multiplex PCR (4, 5) .
Phylogenetic groups (A, B1, B2, and D) were determined as reported (6) . Screening for sequence type (ST) 131 was conducted by using PCR and confi rmed by using multilocus sequence typing (7, 8) . Pulsed-fi eld gel electrophoresis was performed to determine clonal relationships by using XbaI and the protocol available through the PulseNet (www.cdc.gov/pulsenet/ protocols.htm). Banding patterns were analyzed by using BioNumerics software version 6.01 (Applied Maths, Sint-Martens-Latem, Belgium).
Among 104 meat samples, 9 contained cephalosporin-resistant E. coli, resulting in an overall prevalence of 8.7% (95% CI 4.0%-15.8%). Cephalosporin-resistant E. coli was isolated from 7 (31.8%) of 22 chicken, 1 (10.0%) of 10 turkey, and 1 (2.3%) of 42 pork samples. No cephalosporinresistant E. coli was detected from beef and lamb samples. Incidence of samples with cephalosporin-resistant E. coli was lower than in our previous study (2) . This fi nding may be caused by different types of samples included in the studies or a true decrease in incidence.
Features of cephalosporinresistant E. coli identifi ed are summarized in the Table. None produced ESBL, but all 9 isolates were positive for the CMY-2 β-lactamase gene and positive results were confi rmed by sequencing. CMY-2 is the most commonly observed acquired AmpC β-lactamase in E. coli and nontyphoidal Salmonella species in meat products (9) .
As for the phylogenetic groups, 6 (66.7%) of 9 cephalosporinresistant E. coli belonged to group A, which is generally considered to be a commensal phylogenetic group. However, 1 group B2 isolate from a chicken sample was identifi ed as ST131. The CMY-2 gene was located on an IncI1-type plasmid and was transferable to another E. coli strain by conjugation for this isolate. Two group D isolates from chicken that belonged to ST117, which has been reported in ESBL-producing isolates of human and animal origins (10); no clonality was observed for the other 7 isolates by pulsed-fi eld gel electrophoresis, E. coli ST131 has emerged as a worldwide pathogen and causes mainly community-onset extraintestinal infections. Although the pandemic spread of E. coli ST131 was fi rst identifi ed in isolates producing CTX-M-15 ESBL, it is increasingly recognized that isolates belonging to this clone may also harbor other drug resistance determinants. Among acquired AmpC β-lactamases, CMY-2 has been most frequently reported in ST131 from human clinical isolates (3) . Infections caused by CMYproducing E. coli are common but underrecognized because of the lack of standardized detection methods (2) .
Given the rapid global spread of the ST131 clone and the possibility of its transmission from food animals to humans, coupled with an abundance of CMY-2-encoding plasmids in poultry environments, E. coli ST131 producing CMY-2 β-lactamase may have potential to spread to humans. Our results also show that E. coli producing CMY-2 continues to be found commonly among retail chicken products in our study area. 
